Bio-Rad Laboratories Earnings: Your Sneak Peek to the Big Announcement
Bio-Rad Laboratories (NYSE:BIO) will report earnings after markets close on Tuesday, May 7th. Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation. The Company’s products and systems separate complex chemical and biological materials, as well as identify, analyze, and purify their components.
Here is your Cheat Sheet to Bio-rad Laboratories Earnings:
Earnings Expectations: Analysts expect earnings of $1.06 per share on revenues of $506.34 million. Currently, the company’s P/E ratio stands at 20.56.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.47 to a profit $1.35. For the current year, the average estimate is a profit of $5.52, which is better than the estimate ninety days ago.
Here’s how Bio-rad Laboratories has been performing on an annual basis:
|Revenue ($) in millions||1,764||1,784||1,927||2,074||2,069|
|Diluted EPS ($)||3.24||5.20||6.59||6.26||5.72|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||550.24||486.28||510.42||498.70||573.84|
|Diluted EPS ($)||2.078||1.09||1.69||1.48||1.463|
Bio-rad Laboratories has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)